News & Articles

Phase 1 trial in aggressive brain cancer (glioblastoma) is the first clinical trial of uTREAT belonging to Curasight's treatment platform

University of Cambridge researcher spotlights a novel radiotracer during ELRIG Drug Discovery 2025

Facility designed to advance the next generation of imaging systems

New UK-based technical innovation facility opens in Nuneaton on MIRA Tech Park

Discover how real-time, high-throughput imaging and analysis with Countstar Spica M1 is transforming cancer research

Learn how one scientist is harnessing the latest imaging technology to advance his research and generate high-resolution images of neural tissue

Vireo™ promises to enable high-speed, AI-driven live-cell imaging for drug discovery

Revvity is set to unveil its new Phenologic.AI software at SLAS2025 International Conference & Exhibition in San Diego, California

Philipp Wachter discusses the potential for innovative cell culture membrane inserts to supercharge drug discovery efforts

Learn how researchers used the Orion™ platform from RareCyte to generate spatial insights into tumor microenvironments

Microstructural ‘fingerprints’ of inhalation powders revealed by AI image analysis could help scientists develop better treatments for asthma

Yokogawa's Single Cellome System SS2000 uses confocal imaging technology to help abrogate challenges with single-cell lipidomics

In the fast-paced world of science, knowledge drives progress, and The Bio-Rad Academy leads the charge

This feature explores the latest spatial biology research and the technology driving these breakthroughs

Expand horizons in life science research and discover the power of real-time cell monitoring

Axion BioSystems' Maestro MEA and Z platforms now automatically link with Omni imagers, offering enhanced live-cell analysis

Discover how the Wellcome Sanger Institute is helping to develop a physical atlas of all human organs

As we celebrate the first regulatory approval of a gene-editing based therapeutic, Casgevy™, for the treatment of sickle cell disease and transfusion-dependent β-thalassemia, we consider the gene-editing challenges that must be overcome before CRISPR gene-editing technology becomes a common treatment modality

Strategic partnership harnesses respective organ-specific expertise to provide complete human-derived organ-on-a-chip solution for more accurate in vitro ADME predictions

Explore the impact this technology-driven approach has had on the pharmaceutical industry

The expansion introduces state-of-the-art preclinical imaging systems

Automation of emerging technologies is fast-tracking spatial biology breakthroughs

The brand-new SelectScience T-shirts and EXCLUSIVE festive sweater are here, find out how you could win one